$MLKN

MLKN Q1 2027 Earnings Call Transcript

MillerKnoll reported Q1 2027 net sales of $923.4M, down 3.4% YoY, with adjusted EPS of $0.53. Orders grew 3.2% to $913.9M, driven by international and retail segments. Q2 revenue guidance is $972M-$1.012B, and full-year revenue is expected at $3.88B-$4.03B. The company faces tariff impacts and inventory challenges but maintains full-year EPS guidance through cost controls.

Original reporting
Published Sep 22, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MLKN Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$MLKNNeutralMed
01

Why it matters

The earnings release provides fresh guidance and segment trends that traders can use for positioning.

02

Market read

First‑quarter earnings and FY guidance are primary drivers for short‑term price action.

03

What to watch

Tariff refunds and AI‑driven marketing spend may improve future profitability.

Relevance 8/10Novelty 8/10Timing: post-earnings Q1 2027 release

Background

MillerKnoll (NASDAQ:MLKN) reported its first quarter FY27 results, highlighting mixed performance across segments.

Company-level read

Ticker impact

$MLKNNeutralMedium confidence
Context

Q1 2027 earnings release with net sales $923.4M, adjusted EPS $0.53 and updated FY guidance.

Expected impact

Potential short-term downside as investors digest slower revenue growth versus strong margin.

Evidence & confidence

Guidance below prior estimates and a 3.4% sales decline suggest earnings pressure despite margin expansion.

Market effects

Furniture and office solutions sector may see broader scrutiny on demand trends.

North America contract slowdown could affect related suppliers.

International order growth may offset US weakness, influencing global office‑furnishings outlook.

Counterpoint

Margin strength and international order growth could support a rebound if cost controls hold.

Key entities

  • MillerKnoll, Inc.

    US‑listed office furniture manufacturer.

Related articles

$MLKNMedAI 8/10

Profit Gains Might Change The Case For Investing In MillerKnoll Stock (MLKN)

MillerKnoll (MLKN) reported Q1 2026 sales of $923.4M, net income of $26.6M, and EPS of $0.38, up from the prior year despite lower sales. The company attributed this to cost control and operational efficiency. Analysts focus on maintaining margins amid tariffs and macroeconomic shifts, with revenue and earnings projections for 2029 at $4.4B and $188.1M, respectively.

$MLKNMedAI 8/10

Is MillerKnoll’s (MLKN) Growing Order Book a Buy Signal?

MillerKnoll (MLKN) reported Q1 FY2027 with net sales down 3.4% YoY to $923.4M, but orders rose 3.2% to $913.9M. International and retail orders grew, while North America contract lagged. The company cited timing issues for the softness. Adjusted gross margin improved to 41.8%, and operating cash flow rose to $49.1M. Management expects order momentum to continue, despite trade friction and project conversion delays.

$MLKNHighAI 9/10

MillerKnoll Q1 Earnings Call Highlights

MillerKnoll (MLKN) reported Q1 results, declaring a $0.1875 quarterly dividend. North America Contract sales fell 5.3% to $506M, while orders declined 1.7% to $484M. International Contract revenue dropped 6.4% to $157M, but orders rose 17.3% to $181M. Retail sales increased 2.6% to $261M. The company lowered its fiscal 2027 sales outlook to $3.88B-$4.03B, citing weaker-than-expected Q1 performance. Management expects North America Contract growth in fiscal 2027.

$MLKNMed

MLKN Q3 Deep Dive: Margin Strength Offsets Softer Revenue and Lowered Outlook

MillerKnoll (MLKN) reported Q3 revenue of $923.4M, down 3.4% YoY, missing estimates. Q4 guidance of $992M also fell short. Earnings per share beat expectations at $0.53. Management cited delayed projects and softer demand in North America Contract and healthcare, while international orders and retail showed resilience. Cost controls helped margins. The stock trades at $20.57.

$MLKNMedAI 8/10

MillerKnoll (MLKN) Stock Shrugs Off Profit Beat As Tariff Risks Linger

MillerKnoll (MLKN) reported Q1 2027 revenue of $923.4M, down 3.4% YoY, but earnings per share rose 30.1% to $0.38. The stock remained flat post-earnings. Bulls highlight cost discipline and margin improvements, while bears point to tariff risks and soft top-line growth. The company's P/E ratio is 14.1x, and debt coverage remains a focus.